What does CUSIP 04280A100 represent in this 13F holders report?

CUSIP 04280A100 is the security identifier for ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock in Q1 2020?

228 institutional investors reported ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock for Q1 2020. Use the holders table for investor-level position and value details.

ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR)

CUSIP: 04280A100

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Stock
Shares outstanding: 135,488,140
Total 13F shares: 65,790,124
Share change: +1,268,201
Total reported value: $1,891,626,404
Put/Call ratio: 100%
Price per share: $28.77
Number of holders: 228
Value change: -$65,617,767
Number of buys: 111
Number of sells: 170

Quarterly Holders Quick Answers

What is CUSIP 04280A100?
CUSIP 04280A100 identifies ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 04280A100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	9.1%	12,360,958	$784,054,000	—	31 Dec 2019	13F
VANGUARD GROUP INC	13F	Company	7.2%	9,797,507	$621,455,000	—	31 Dec 2019	13F
STATE STREET CORP	13F	Company	3%	4,124,470	$261,615,000	—	31 Dec 2019	13F
Invesco Ltd.	13F	Company	2.4%	3,290,359	$208,707,000	—	31 Dec 2019	13F
Johnson & Johnson Innovation - JJDC, Inc.	13F	Company	2.4%	3,260,869	$206,837,000	—	31 Dec 2019	13F
FIRST MANHATTAN CO. LLC.	13F	Company	1.5%	2,068,020	$131,174,000	—	31 Dec 2019	13F
FMR LLC	13F	Company	1.4%	1,881,408	$119,338,000	—	31 Dec 2019	13F
NORTHERN TRUST CORP	13F	Company	1.1%	1,552,707	$98,489,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.1%	1,432,361	$90,854,000	—	31 Dec 2019	13F
Fiera Capital Corp	13F	Company	1%	1,365,446	$86,610,000	—	31 Dec 2019	13F
Bank of New York Mellon Corp	13F	Company	0.78%	1,062,801	$67,415,000	—	31 Dec 2019	13F
NORGES BANK	13F	Company	0.77%	1,044,194	$66,233,000	—	31 Dec 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.65%	876,755	$55,613,000	—	31 Dec 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.53%	722,300	$45,815,000	—	31 Dec 2019	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.52%	704,064	$44,658,000	—	31 Dec 2019	13F
D. E. Shaw & Co., Inc.	13F	Company	0.51%	692,895	$43,950,000	—	31 Dec 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.46%	629,061	$39,902,000	—	31 Dec 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.42%	572,640	$36,323,000	—	31 Dec 2019	13F
1832 Asset Management L.P.	13F	Company	0.4%	543,940	$34,372,000	—	31 Dec 2019	13F
CARILLON TOWER ADVISERS, INC.	13F	Company	0.38%	513,553	$32,574,667	—	31 Dec 2019	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.38%	509,670	$32,329,000	—	31 Dec 2019	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	0.35%	470,679	$29,855,000	—	31 Dec 2019	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.33%	442,500	$28,068,000	—	31 Dec 2019	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.32%	433,617	$27,504,000	—	31 Dec 2019	13F
MORGAN STANLEY	13F	Company	0.31%	420,328	$26,661,000	—	31 Dec 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.3%	405,533	$25,722,000	—	31 Dec 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.29%	392,174	$24,873,000	—	31 Dec 2019	13F
CREDIT SUISSE AG/	13F	Company	0.28%	381,224	$24,182,000	—	31 Dec 2019	13F
Nuveen Asset Management, LLC	13F	Company	0.27%	371,901	$23,589,000	—	31 Dec 2019	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.27%	361,434	$22,926,000	—	31 Dec 2019	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.27%	360,622	$22,874,000	—	31 Dec 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.24%	330,120	$20,940,000	—	31 Dec 2019	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.24%	330,029	$20,934,000	—	31 Dec 2019	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.23%	308,082	$19,542,000	—	31 Dec 2019	13F
FEDERATED HERMES, INC.	13F	Company	0.23%	306,575	$19,446,000	—	31 Dec 2019	13F
RHUMBLINE ADVISERS	13F	Company	0.23%	305,374	$19,370,000	—	31 Dec 2019	13F
HRT FINANCIAL LP	13F	Company	0.22%	299,297	$18,984,000	—	31 Dec 2019	13F
S.c.a. Candriam	13F	Individual	0.21%	282,508	$17,919,000	—	31 Dec 2019	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.21%	279,090	$17,703,000	—	31 Dec 2019	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.18%	250,099	$15,864,000	—	31 Dec 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.17%	234,225	$14,857,000	—	31 Dec 2019	13F
UBS Group AG	13F	Company	0.15%	208,175	$13,204,000	—	31 Dec 2019	13F
Man Group plc	13F	Company	0.15%	207,649	$13,171,000	—	31 Dec 2019	13F
FIRST TRUST ADVISORS LP	13F	Company	0.15%	202,442	$12,841,000	—	31 Dec 2019	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.14%	193,774	$12,291,000	—	31 Dec 2019	13F
Matarin Capital Management, LLC	13F	Company	0.14%	193,171	$12,253,000	—	31 Dec 2019	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.13%	175,000	$11,100,000	—	31 Dec 2019	13F
Swiss National Bank	13F	Company	0.12%	164,200	$10,415,000	—	31 Dec 2019	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.12%	156,451	$9,924,000	—	31 Dec 2019	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.11%	154,200	$9,781,000	—	31 Dec 2019	13F

Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) as of Q1 2020

As of 31 Mar 2020, ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) was held by 228 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 65,790,124 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Johnson & Johnson Innovation - JJDC, Inc., Invesco Ltd., FMR LLC, NORTHERN TRUST CORP, FIRST MANHATTAN CO, GEODE CAPITAL MANAGEMENT, LLC, and FIERA CAPITAL CORP. This page lists 228 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

284

Q1 2020 holders

228

Holder diff

-56

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.